Significant movement in price has been observed in Mangalam Drugs And Organics Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Mangalam Drugs And Organics Limited has submitted their response.
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE's Surveillance Department wrote to Mangalam Drugs and Organics after observing unusual price movement in the stock. The company replied that it has no connection to the price movement and that such movement is driven purely by market sentiment. The Managing Director confirmed there is no pending material information or announcement that could impact the share price. The letter was signed on January 7, 2026, in response to NSE's query dated January 5, 2026.
This is a routine surveillance clarification with no negative regulatory action implied. The company's response is neutral and may help calm speculation, but the stock may remain volatile until trading normalises.